InvestorsHub Logo
Followers 17
Posts 581
Boards Moderated 0
Alias Born 05/18/2018

Re: anders2211 post# 230277

Tuesday, 01/14/2020 1:22:08 PM

Tuesday, January 14, 2020 1:22:08 PM

Post# of 462348
Anders, I have a relative with Autism too, so I have some skin in that game also. I will say, there is no proof that A2-73 will have ANY affect on autism, and I do not want to argue that point. However, as you know A2-73 appears to be a general cns drug, so it MAY help with autism. As you have seen in the last few years we are still learning how A2-73 works, from homeostasis, to gut biomes, to gaba glutamate ratios. No one can say NOW, how exactly 2-73 could affect autism. A2-73 might relate to autism (genetic) the way it relates to RettS( genetic). It may not be a cure but it may improve some symptoms and quality of life. That is my hope.

There will need to be trials run to know exactly the affect of 2-73 on autism. That said, with PD provisional approval, as I understand it in the U.S., a doctor could prescribe A2-73 for autism, before/parallel to autism trial. That is also my hope. Not sure about the laws in your country, lol talk to a lawyer...yourself.

As Jimmy pointed out, patents are written as broadly as possible, and frequently before there is actual proof that the invention works. That is what anavex does, and then writes more patents as more is learned.

Plenty of reason to be hopeful, and I think you are on the right track trying to get your hands on some A2-73.

Good luck my friend!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News